(Q44239117)

English

A multicenter phase II study of the intravenous administration of liposomal tretinoin in patients with acquired immunodeficiency syndrome-associated Kaposi's sarcoma

scientific article published in December 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

A multicenter phase II study of the intravenous administration of liposomal tretinoin in patients with acquired immunodeficiency syndrome-associated Kaposi's sarcoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1 reference

based on heuristic

inferred from title

author name string

Zale P Bernstein

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Asher Chanan-Khan

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Kena C Miller

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Donald W Northfelt

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Gabriel Lopez-Berestein

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Parkash S Gill

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

language of work or name

0 references

publication date

1 December 2002

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

95

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

2555-2561

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Kaposi's sarcoma in HIV-infected patients: treatment options

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11009

7 January 2021

based on heuristic

inferred from DOI database lookup

Administration of pentosan polysulfate to patients with human immunodeficiency virus-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11009

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiproliferative effect of retinoid compounds on Kaposi's sarcoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11009

7 January 2021

based on heuristic

inferred from DOI database lookup

Retinoid antagonism of NF-IL6: insight into the mechanism of antiproliferative effects of retinoids in Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11009

7 January 2021

based on heuristic

inferred from DOI database lookup

Topical treatment of epidemic Kaposi's sarcoma with all-trans-retinoic acid

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11009

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/II study of intermittent all-trans-retinoic acid, alone and in combination with interferon alfa-2a, in patients with epidemic Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11009

7 January 2021

based on heuristic

inferred from DOI database lookup

Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11009

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11009

7 January 2021

based on heuristic

inferred from DOI database lookup

Failure of isotretinoin in Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11009

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11009

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic treatment of AIDS-related Kaposi's sarcoma: Results of a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11009

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11009

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11009

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11009

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.11009

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44239117&oldid=2108846843"